Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] (RESTORE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04945772 |
Recruitment Status :
Completed
First Posted : June 30, 2021
Last Update Posted : March 22, 2024
|
Sponsor:
Nanoscope Therapeutics Inc.
Information provided by (Responsible Party):
Nanoscope Therapeutics Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | February 27, 2023 |
Actual Study Completion Date : | January 18, 2024 |
Certification/Extension First Submitted : | February 19, 2024 |